Wake-Up Stroke Management
For patients with wake-up stroke (acute ischemic stroke with unknown onset time), administer IV thrombolysis if they are within 4.5 hours of symptom recognition and MRI shows DWI-FLAIR mismatch (DWI lesion <1/3 MCA territory with no marked FLAIR hyperintensity), or use CT/MR perfusion imaging to identify salvageable penumbra for treatment up to 9-24 hours from last known well. 1
Imaging-Based Treatment Algorithm
Within 4.5 Hours of Symptom Recognition (When Patient Awakens)
MRI-Based Selection (WAKE-UP Protocol):
- Obtain emergent MRI with DWI and FLAIR sequences 1
- Treat with IV thrombolysis if:
- DWI lesion is present but smaller than one-third of MCA territory
- No marked (clearly visible) FLAIR hyperintensity in the same region as DWI lesion
- Subtle FLAIR changes are acceptable (signal intensity ratio <1.2 between affected and mirror regions) 1
- This approach achieved 53.3% excellent outcomes (mRS 0-1) versus 41.8% with placebo 1
This MRI mismatch paradigm identifies patients whose biological stroke onset is likely within 4.5 hours, even though clock time is unknown. The WAKE-UP trial demonstrated clear benefit with this selection method 1, 2, 3.
Beyond 4.5 Hours from Last Known Well (4.5-24 Hour Window)
Perfusion-Based Selection:
For 4.5-9 hour window:
- Obtain CT perfusion or MR DWI-PWI with automated postprocessing 1
- Treat if salvageable ischemic penumbra is present
- The EXTEND trial showed 35.4% versus 29.5% excellent outcomes (adjusted RR 1.44) despite increased symptomatic ICH risk (6.2% vs 0.9%) 1
For 4.5-24 hour window with large vessel occlusion:
- If patient cannot receive endovascular thrombectomy but has salvageable penumbra on perfusion imaging
- IV thrombolysis may be beneficial when administered by stroke experts 1
- This represents a Class 2b recommendation (lower certainty but potential benefit)
Safety Profile
Symptomatic intracranial hemorrhage risk: 3% with thrombolysis versus 1% with control in wake-up stroke patients 3. Meta-analysis of extended window trials confirmed increased sICH risk (adjusted OR 9.7) but overall benefit in functional outcomes (adjusted OR 1.86 for mRS 0-1) 1.
Mortality: No significant difference at 90 days (4.0% thrombolysis vs 1.9% control, p=0.162 in wake-up cohorts) 4, 3.
Critical Implementation Points
- Imaging must be performed rapidly (target <25 minutes) to facilitate timely treatment 1
- Do not delay vascular imaging (CTA/CTP) to obtain serum creatinine 1
- Wake-up stroke patients show similar clinical and imaging characteristics to known-onset strokes, suggesting ictus occurs just before awakening 5
- Approximately 25% of all acute ischemic strokes are wake-up strokes 6
- Over 80% of surveyed hospitals now follow standardized institutional protocols for wake-up stroke 6
Endovascular Thrombectomy Consideration
For wake-up strokes with large vessel occlusion:
- Emergent brain and vascular imaging (CT/CTA or MRI/MRA) should be performed immediately 1
- In the 6-24 hour window, use adjunctive perfusion imaging for EVT selection 1
- EVT in selected wake-up stroke patients with LVO achieved 46% excellent outcomes versus 9% with control (RR 5.12) 3
Common Pitfalls to Avoid
- Do not automatically exclude wake-up stroke patients from thrombolysis based solely on unknown time—use imaging selection criteria
- Subtle FLAIR changes are acceptable in the WAKE-UP paradigm; only marked/clearly visible FLAIR hyperintensity is exclusionary 1
- Do not delay imaging for laboratory results when considering advanced imaging with contrast 1
- Recognize that non-wake-up unwitnessed strokes may have similar treatment effects, though evidence is less robust due to smaller sample sizes 4
The paradigm shift from strict time-based to tissue-based selection has substantially expanded treatment eligibility for wake-up stroke patients, with high-certainty evidence supporting both MRI-based and perfusion-based selection strategies 1, 2, 3.